Abstract
The acidity of the refluxate into the esophagus is an important factor not only for reflux esophagitis, but also for Barrett’s esophagus and the development of Barrett’s esophageal cancer. On the other hand, H. pylori infection is thought to prevent reflux esophagitis and Barrett’s esophagus by causing atrophic gastritis, which in turn decreases gastric acid secretion. Moreover, the preservation of gastric acid secretion may be important for the development of gastroesophageal junction cancer, including Barrett’s esophageal cancer, irrespective of the H. pylori infection status. An increase in gastric acid secretion in Japanese populations has been predicted based on a decreasing rate of H. pylori infection and the westernization of eating habits in Japan; this, in turn, may lead to an increase in the prevalence of Barrett’s esophageal cancer in Japan in the future.
Similar content being viewed by others
References
Spechler SJ. Barrett’s esophagus. N Eng J Med. 1986;315:362–71.
Hassall E. Barrett’s esophagus: congenital or acquired? Am J Gastroenterol. 1993;88:819–24.
Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complication with Barrett’s esophagus. Am J Gastroenterol. 1997;92:27–31.
Haggitt RC. Barrett’s esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994;25:982–93.
Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-esophageal junction. Lancet. 1994;344:1533–6.
Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameter Committee of the American College of Gastroenterology. Am J Gastroenterol. 1998;93:1028–32.
Takubo K, Aida J, Sawabe M, Arita T, Kato H, Pech O, et al. The normal anatomy around the oesophagogastric junction: a histopathologic view and its correlation with endoscopy. Best Pract Res Clin Gastroenterol. 2008;22:569–83.
Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric jynction. Gastoroenterology. 1999;116:277–85.
Hongo M, Shoji T. Epidemiology of reflux disease and CLE in east Asia. J Gastroenterol. 2003;38(Suppl):25–30.
Azuma N, Endo T, Arimura Y, Motoya S, Itoh F, Hinoda Y, et al. Prevalence of Barrett’s esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett’s esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol. 2000;35:583–92.
Kawano T, Kouzu T, Kawano T, Ohara S. The prevalence of Barrett’s mucosa in the Japanese (in Japanese with English abstract). Gastroenterol Endosc. 2005;47:951–61.
Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–53.
Takubo K, Aida J, Sawabe M, Kurosumi M, Arima M, Fujishiro M, et al. Early squamous cell carcinoma of the esophagus: the Japanese viewpoint. Histopathology. 2007;51:733–42.
Bar-Maor JA, He YR, Li D. Barrett’s epithelium with complete stricture of the esophagus: hypothesis of its etiology. J Pediatr Surg. 1995;30:893–5.
Hennessy TP, Edlich RF, Buchin RJ, Tsung MS, Prevost M, Wangensteen OH. Influence on gastroesophageal incompetence on regeneration of esophageal mucosa. Arch Surg. 1968;97:105–7.
Corder AP, Jones RH, Sadler RH, Daniels P, Johnson CD. Heart-burn, oesophagitis and Barrett’s esophagus in self-medicating patients in general practice. Br J Clin Pract. 1996;50:245–8.
Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF 3rd, et al. Barrett’s esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92:118–24.
Csendes A, Smok G, Burdiles P, Quesada F, Huertas C, Rojas J, et al. Prevalence of Barrett’s esophagus by endoscopy and histologic studies : a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus. 2000;13:5–11.
Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett’s esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol. 1997;92:1293–7.
Romero Y, Cameron AJ, Schaid DJ, McDonnell SK, Burgart LJ, Hardtke CL, et al. Barrett’s esophagus: prevalence in symptomatic relatives. Am J Gastroenterol. 2002;97:1127–32.
Fass R, Hell RW, Garewal HS, Martnez P, Pulliam G, Wendel C, et al. Correlation of oesophageal acid exposure with Barrett’s oesophagus length. Gut. 2001;48:310–3.
Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996;111:1192–9.
Nehra D, Howell P, Williams CP, Pye JK, Beynon J. Toxic bile acids in gastro-esophageal reflux disease: influence of gastric acidity. Gut. 1999;44:598–602.
Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett’s length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol. 2002;97:930–1936.
Iijima K, Ohara S, Sekine H, Koike T, Kubota Y, Kato K, et al. A new endoscopic method of gastric acid secretory testing. Am J Gastroenterol. 1998;93:2113–8.
Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut. 2000;46:20–6.
Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydiria. Aliment Pharmacol Ther. 2004;19:1181–8.
Iijima K, Ohara S, Koike T, Sekine H, Shimosegawa T. Gastric acid secretion of normal Japanese subjects in relation to Helicobacter pylori infection, aging, and gender. Scand J Gastroenterol. 2004;8:709–16.
Kato S, Ozawa K, Koike T, Sekine H, Ohara S, Minoura T, et al. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children. Helicobacter. 2004;9:100–5.
Koike T, Ohara S, Sekine H, Iijima K, Kato K, Shimosegawa T, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol. 1999;94:3468–72.
Koike T, Ohara S, Sekine H, iijima K, Abe Y, Kato K, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 2001;49:330–4.
Corley DA, Kubo A, Levin TR, eBlock G, Habel L, Zhao W, et al. Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study. Gut. 2008;57:727–33.
Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett’s esophagus, Barrett’s dysplasia, and Barrett’s adenocarcinoma. Am J Gastroenterol. 2000;95:387–94.
Quddus MR, Henley JD, Sulaiman RA, Paumbo TC, Gnepp DR. Helicobacter pylori infection and adenocarcinoma arising in Barrett’s esophagus. Hum Pathol. 1997;28:1007–9.
Henihan RD, Stuart RC, Nolan N, Gorey TF, Hennessy TP, O’Morain CA. Barrett’s esophagus and the presence of Helicobacter pylori. Am J Gastroenterol. 1998;93:542–6.
Abe Y, Ohara S, Koike T, Sekine H, Iijima K, Kawamura M, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett’s esophagus in Japan. Am J Gastroenterol. 2004;99:1213–21.
Inomata Y, Koike T, Ohara S, Abe Y, Sekine H, Iijima K, et al. Presevation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol. 2006;101:926–33.
Koike T, Ohara S, Inomata Y, Abe Y, Iijima K, Shimosegawa T. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan. Inflammopharmacology. 2007;15:61–4.
Kuipers EJ, Perez-Perez GI, Meuwissenn SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87:1777–80.
Yasunaga Y, Shinomura Y, Kanayama S, Higashimoto Y, Yabu M, Miyazaki Y, et al. Mucosal interleukin 1 beta production and acid secretion in enlarged fold gastritis. Aliment Pharmacol Ther. 1997;11:801–9.
El-Omar EM. The importance of interleukin 1-beta in Helicobacter pylori associated disease. Gut. 2001;48:743–7.
Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, et al. The polymorphism interleukin-8 251 A/T influences the susceptibility of Helicobacter pylori-related gastric diseases in the Japanese population. Gut. 2005;54:330–5.
Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T, et al. Contribution of HLA-DQA gene to hosts response against H. pylori. Lancet. 1994;343:542–3.
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Voqelman JH, Orenterich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.
Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325:1132–6.
Haung JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169–79.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.
Svendsen JH, Svendsen CD, Christiansen PM. Gastric cancer risk in achlorhydric patients. A long-term follow-up study. Scand J Gastroenterol. 1986;21:16–20.
Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer. 1994;73:2691–4.
Iijima K, Henry E, Moriya A, Wirz A, Kelman AW, McColl KE. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology. 2002;122:1248–57.
Asanuma K, Iijima K, Sugata H, Ohara S, Shimosegawa T, Yoshimura T. Diffusion of cytotoxic concentrations of nitric oxide generated luminally at the gastro-oesophageal junction of rats. Gut. 2005;54:1072–7.
Suzuki H, Iijima K, Scobie G, Fyfe V, McColl KE. Nitrate and nitrosative chemistry within Barrett’s oesophagus during acid reflux. Gut. 2005;54:1527–35.
Ara N, Iijima K, Asanuma K, Yoshitaka J, Ohara S, Shimosegawa T, et al. Disruption of gastric barrier function by luminal nitrosative stress: a potential chemical insult to the human gastro-oesophageal junction. Gut. 2008;57:306–13.
Manabe N, Yoshihara M, Sasaki A, Tanaka S, Haruma K, Chayama K. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol. 2002;17:949–54.
Iwakiri K, Sugiura T, Hayashi Y, Kotoyori M, Kawakami A, Makino H, et al. Esophageal motility in Japanese patients with Barrett’s esophagus. J Gastroenterol. 2003;38:1036–41.
Zentilin P, Reglioni S, Savarino V. Pathophysiological characterisitics of long and short segment Barrett’s esophagus. Scand J Gastroenterol. 2003;239(Suppl 38):40–3.
Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogen in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.
Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol. 1999;94:2094–9.
Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41:452–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koike, T., Ohara, S. & Shimosegawa, T. Role of gastric acid secretion in the pathogenesis of Barrett’s esophageal cancer in a Japanese population. Clin J Gastroenterol 2, 143–148 (2009). https://doi.org/10.1007/s12328-009-0082-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-009-0082-z